July 19, 2017
Genetic testing for earlier diagnosis and treatment of rheumatoid arthritis
By Sharon Rosen
If you are one of the estimated 1.5 million Americans who suffer from rheumatoid arthritis, you know about the painful, swollen and stiff joints that are common symptoms of this chronic inflammatory disorder. Mayo Clinic has been a leader in discovering biomarkers – indicators of health and disease – that link rheumatoid arthritis to the […]
Tags: #CIMCon17, #Dr. Carla Wijbrandts, #Dr. Paul-Peter Tak, #drug response, #drug safety, #Individualizing Medicine 2017, biomarkers, center for individualized medicine, Dr. Eric Matteson, individualized medicine, mayo clinic, Mayo Clinic Proceedings
June 30, 2017
Pharmacogenomics – striving for safer, more effective drugs for you
By Sharon Rosen
At Mayo Clinic, pharmacogenomics – how your genes impact the way you process medications – is helping doctors to take the guess work out of selecting safer, more effective treatment for patients. Mayo researchers have been leaders in developing DNA tests and identifying drug-gene interactions that affect a patient’s response to many medications, such as […]
Tags: #CIMCon17, #drug safety, #drug-gene reactions, #Karen Daggett, center for individualized medicine, Dr. Eric Matey, Dr. Liewei Wang, Dr. Richard Weinshilboum, Heart Disease, mayo clinic, Mayo Clinic Pharmacogenomics Program, medical research